Lensar (LNSR) EPS (Basic) Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.42% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.04% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.88% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 95.65% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 8.20% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 92.59% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.89% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 51.01% |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | 167.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 167.24% |
| Dec 31, 2025 | 92.59% |
| Sep 30, 2025 | -138.46% |
| Jun 30, 2025 | 81.01% |
| Mar 31, 2025 | -1,121.05% |
| Dec 31, 2024 | -362.86% |
| Sep 30, 2024 | -200.00% |
| Jun 30, 2024 | 2.47% |
| Mar 31, 2024 | 52.50% |
| Dec 31, 2023 | -52.17% |
| Sep 30, 2023 | 133.33% |
| Jun 30, 2023 | -20.90% |
| Mar 31, 2023 | 40.30% |
| Dec 31, 2022 | 42.50% |
| Sep 30, 2022 | 40.00% |
| Jun 30, 2022 | -42.55% |
| Mar 31, 2022 | -19.64% |
| Dec 31, 2021 | -66.67% |
| Sep 30, 2021 | -1.56% |
| Jun 30, 2021 | 88.81% |
| Mar 31, 2021 | 83.72% |
| Dec 31, 2020 | 89.61% |
| Sep 30, 2020 | 88.24% |